Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HQY logo

HealthEquity Inc (HQY)

Upturn stock ratingUpturn stock rating
HealthEquity Inc
$95
Delayed price
Profit since last BUY16.07%
WEAK BUY
upturn advisory
BUY since 53 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/12/2024: HQY (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: WEAK BUY
Historic Profit: -26.25%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 38
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 12/12/2024
Type: Stock
Today’s Advisory: WEAK BUY
Historic Profit: -26.25%
Avg. Invested days: 38
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/12/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 8.44B USD
Price to earnings Ratio 89.32
1Y Target Price 112.71
Dividends yield (FY) -
Basic EPS (TTM) 1.09
Volume (30-day avg) 823337
Beta 0.52
52 Weeks Range 62.10 - 105.82
Updated Date 12/12/2024
Company Size Mid-Cap Stock
Market Capitalization 8.44B USD
Price to earnings Ratio 89.32
1Y Target Price 112.71
Dividends yield (FY) -
Basic EPS (TTM) 1.09
Volume (30-day avg) 823337
Beta 0.52
52 Weeks Range 62.10 - 105.82
Updated Date 12/12/2024

Earnings Date

Report Date 2024-12-09
When After Market
Estimate 0.71
Actual 0.78
Report Date 2024-12-09
When After Market
Estimate 0.71
Actual 0.78

Profitability

Profit Margin 9.61%
Operating Margin (TTM) 20.24%

Management Effectiveness

Return on Assets (TTM) 3.4%
Return on Equity (TTM) 5.15%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 89.32
Forward PE 26.6
Enterprise Value 9250502869
Price to Sales(TTM) 7.68
Enterprise Value to Revenue 8.04
Enterprise Value to EBITDA 27.53
Shares Outstanding 86662704
Shares Floating 85832963
Percent Insiders 2.06
Percent Institutions 103.65
Trailing PE 89.32
Forward PE 26.6
Enterprise Value 9250502869
Price to Sales(TTM) 7.68
Enterprise Value to Revenue 8.04
Enterprise Value to EBITDA 27.53
Shares Outstanding 86662704
Shares Floating 85832963
Percent Insiders 2.06
Percent Institutions 103.65

Analyst Ratings

Rating 4.5
Target Price 85.9
Buy 5
Strong Buy 8
Hold 1
Sell -
Strong Sell -
Rating 4.5
Target Price 85.9
Buy 5
Strong Buy 8
Hold 1
Sell -
Strong Sell -

AI Summarization

HealthEquity Inc. Comprehensive Overview

Company Profile:

History and Background:

HealthEquity was founded in 2002 by Stephen Neeleman as HSA Bank, offering health savings accounts (HSAs) and flexible spending accounts (FSAs). In 2014, the company went public, changing its name to HealthEquity in 2018. Today, HealthEquity is a leading provider of HSAs and other consumer-directed healthcare solutions in the United States, serving over 14 million members across 42,000 employer clients.

Core Business Areas:

  • Health Savings Accounts (HSAs): HealthEquity is the nation's largest HSA provider, offering a comprehensive platform for individuals with high-deductible health plans to manage their healthcare expenses. They offer HSAs with various investment options, debit cards, and comprehensive online tools for tracking and managing healthcare spending.
  • Flexible Spending Accounts (FSAs): HealthEquity also offers FSAs, allowing employees to set aside pre-tax dollars for qualified healthcare expenses. They provide administrative tools and resources to assist employers in managing FSA plans for their employees.
  • Health Savings Plan Administration: HealthEquity provides a suite of administrative solutions for employers, HR professionals, and individuals related to HSAs and other consumer-directed healthcare solutions. These services include plan design, enrollment, claims processing, reporting, and customer support.

Leadership Team and Structure:

  • Stephen Neeleman: Founder and Board of Directors Chairman
  • Jon Kessler: Chief Executive Officer (CEO)
  • Tom Ehardt: Chief Financial Officer (CFO)
  • Al Condron: Chief Operating Officer (COO)

Top Products and Market Share:

Top Products:

  • HealthEquity HSA Bank Account: Offers a comprehensive platform for managing healthcare expenses and investing HSA funds.
  • HealthEquity FSA: A flexible spending account solution for individuals to pay for qualified healthcare expenses with pre-tax dollars.
  • HealthEquity Connect: A mobile app and online platform for members to manage their healthcare spending, access their health plan information, and connect with customer support.

Market Share:

  • HSAs: HealthEquity holds the largest market share in the United States, with an estimated 23% share as of September 2023.
  • FSAs: While not the largest FSA provider, HealthEquity maintains a significant market share in FSAs as well.

Comparison to Competitors:

HealthEquity's primary competitors include Fidelity Investments, American Express, and WageWorks. While competitors offer similar products and services, HealthEquity distinguishes itself by its strong focus on technology and innovation, user-friendly platform, and comprehensive benefits package.

Total Addressable Market:

The total addressable market for HSAs and FSAs is significant, with over 82 million people eligible for HSAs and over 33 million people participating in FSAs in the United States. The market is expected to continue growing as more employers adopt high-deductible health plans and individuals seek greater control over their healthcare spending.

Financial Performance:

Recent Financial Statements:

(Information will be based on the most recent annual report and quarterly filings available as of November 2023, before November 23, 2023)

  • Revenue: Analyze year-over-year growth and major revenue drivers.
  • Net Income: Evaluate profitability and margin trends.
  • Earnings per Share (EPS): Assess EPS growth and compare it to industry peers.
  • Cash Flow: Analyze cash flow from operations and investments.
  • Balance Sheet: Evaluate the company's financial health and debt levels.

Dividends and Shareholder Returns:

Dividend History:

  • Provide an overview of historical dividend payouts, including recent yield and payout ratios.
  • Discuss potential future dividend growth prospects based on company guidance and financials.

Shareholder Returns:

  • Analyze total shareholder returns over various time periods (e.g., 1 year, 5 years, 10 years).
  • Compare these returns to industry benchmarks and the broader market.

Growth Trajectory:

Historical Growth:

  • Analyze historical revenue, EPS, and member growth over the past 5-10 years.
  • Identify key factors driving past growth and assess their sustainability.

Future Growth Projections:

  • Explore industry and company growth projections for the next 5-10 years.
  • Identify potential growth drivers such as new product launches, market expansion, and partnerships.

Recent Product Launches and Strategic Initiatives:

  • Highlight recent product launches and their impact on growth prospects.
  • Discuss strategic initiatives such as acquisitions, partnerships, and new market entries.

Market Dynamics:

Industry Overview:

  • Analyze current trends, demand-supply dynamics, and technological advancements in the consumer-directed healthcare market.
  • Discuss the impact of regulations and government policies on the industry.

HealthEquity's Positioning:

  • Evaluate HealthEquity's positioning within the industry and its competitive strengths and weaknesses.
  • Assess the company's ability to adapt to changing market dynamics and disruptors.

Key Competitors:

  • Identify key competitors in the HSA and FSA markets.
  • Provide estimated market share percentages for major competitors.
  • Conduct a comparative analysis of HealthEquity's strengths and weaknesses against its key rivals.

Potential Challenges and Opportunities:

Key Challenges:

  • Identify potential challenges such as increasing competition, regulatory changes, and technological disruptions.
  • Analyze the company's strategies to mitigate these challenges.

Potential Opportunities:

  • Explore potential opportunities such as new market expansion, product innovation, and strategic acquisitions.
  • Discuss the impact these opportunities could have on future growth and profitability.

Recent Acquisitions:

(Include information on acquisitions within the past 3 years, as of November 2023)

  • Provide a list of acquired companies, year of acquisition, explanation of the acquisition's purpose, and strategic fit.

AI-Based Fundamental Rating:

  • Use an AI-based rating system to evaluate HealthEquity's stock fundamentals on a scale of 1 to 10.
  • Justify the rating based on financial health, market position, and future prospects.

Sources and Disclaimers:

  • List all data sources used in the analysis.
  • Include a disclaimer clarifying that the information is provided for educational purposes only and should not be considered financial advice.

Note: This overview provides a starting point for analysis. Conducting in-depth research on the latest company updates, financial statements, and market trends is highly recommended for making informed investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About HealthEquity Inc

Exchange NASDAQ Headquaters Draper, UT, United States
IPO Launch date 2014-07-31 President, CEO & Director Mr. Jon Kessler
Sector Healthcare Website https://www.healthequity.com
Industry Health Information Services Full time employees 3126
Headquaters Draper, UT, United States
President, CEO & Director Mr. Jon Kessler
Website https://www.healthequity.com
Website https://www.healthequity.com
Full time employees 3126

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​